Health ❯Drug Development

Clinical Trials

Preclinical Testing Research and Development Phase 3 Studies Pain Relief Medications Regulatory Approval Market Approval FDA Approval Neuropsychiatric Drugs

Johns Hopkins Researchers Grow Vascularized Whole-Brain Organoid With Network-Level Activity

It offers a human-relevant test bed for neuropsychiatric drug screening by replicating early developmental electrical activity.

Merck Completes €3 Billion Springworks Deal in Largest Pharma Acquisition Since 2007

Korean Biotech Firms Mark Record Presence at BIO USA 2025

Sanofi to Acquire Blueprint Medicines for $9.1 Billion to Bolster Rare Immunology Portfolio

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

FDA Approves Regeneron-Sanofi's Dupixent for COPD Treatment

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders